300 related articles for article (PubMed ID: 19291710)
1. Acute hypoxia and osteoclast activity: a balance between enhanced resorption and increased apoptosis.
Knowles HJ; Athanasou NA
J Pathol; 2009 Jun; 218(2):256-64. PubMed ID: 19291710
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia is a major stimulator of osteoclast formation and bone resorption.
Arnett TR; Gibbons DC; Utting JC; Orriss IR; Hoebertz A; Rosendaal M; Meghji S
J Cell Physiol; 2003 Jul; 196(1):2-8. PubMed ID: 12767036
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
5. siRNA targeting HIF-1alpha induces apoptosis of pancreatic cancer cells through NF-kappaB-independent and -dependent pathways under hypoxic conditions.
Chen C; Yu Z
Anticancer Res; 2009 Apr; 29(4):1367-72. PubMed ID: 19414389
[TBL] [Abstract][Full Text] [Related]
6. Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption.
Dodds RA; James IE; Rieman D; Ahern R; Hwang SM; Connor JR; Thompson SD; Veber DF; Drake FH; Holmes S; Lark MW; Gowen M
J Bone Miner Res; 2001 Mar; 16(3):478-86. PubMed ID: 11277265
[TBL] [Abstract][Full Text] [Related]
7. Optimized transfection of diced siRNA into mature primary human osteoclasts: inhibition of cathepsin K mediated bone resorption by siRNA.
Selinger CI; Day CJ; Morrison NA
J Cell Biochem; 2005 Dec; 96(5):996-1002. PubMed ID: 16149069
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
[TBL] [Abstract][Full Text] [Related]
9. A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys.
Kumar S; Dare L; Vasko-Moser JA; James IE; Blake SM; Rickard DJ; Hwang SM; Tomaszek T; Yamashita DS; Marquis RW; Oh H; Jeong JU; Veber DF; Gowen M; Lark MW; Stroup G
Bone; 2007 Jan; 40(1):122-31. PubMed ID: 16962401
[TBL] [Abstract][Full Text] [Related]
10. The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - the In Vitro Osteoclast Differentiation in Arthritis (IODA) study.
Durand M; Boire G; Komarova SV; Dixon SJ; Sims SM; Harrison RE; Nabavi N; Maria O; Manolson MF; Mizianty M; Kurgan L; de Brum-Fernandes AJ
Bone; 2011 Mar; 48(3):588-96. PubMed ID: 20959150
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the kinetics of osteoclastogenesis in arthritic rats.
Schett G; Stolina M; Bolon B; Middleton S; Adlam M; Brown H; Zhu L; Feige U; Zack DJ
Arthritis Rheum; 2005 Oct; 52(10):3192-201. PubMed ID: 16200623
[TBL] [Abstract][Full Text] [Related]
12. Cystatin B as an intracellular modulator of bone resorption.
Laitala-Leinonen T; Rinne R; Saukko P; Väänänen HK; Rinne A
Matrix Biol; 2006 Apr; 25(3):149-57. PubMed ID: 16321512
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a human in vitro resorption assay: demonstration of utility using novel antiresorptive agents.
James IE; Lark MW; Zembryki D; Lee-Rykaczewski EV; Hwang SM; Tomaszek TA; Belfiore P; Gowen M
J Bone Miner Res; 1999 Sep; 14(9):1562-9. PubMed ID: 10469285
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharides (LPS) induce the differentiation of human monocytes to osteoclasts in a tumour necrosis factor (TNF) alpha-dependent manner: a link between infection and pathological bone resorption.
Mörmann M; Thederan M; Nackchbandi I; Giese T; Wagner C; Hänsch GM
Mol Immunol; 2008 Jul; 45(12):3330-7. PubMed ID: 18538847
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4.
Knowles HJ; Cleton-Jansen AM; Korsching E; Athanasou NA
FASEB J; 2010 Dec; 24(12):4648-59. PubMed ID: 20667978
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia/reoxygenation induces CTGF and PAI-1 in cultured human retinal pigment epithelium cells.
Fuchshofer R; Yu AL; Teng HH; Strauss R; Kampik A; Welge-Lussen U
Exp Eye Res; 2009 May; 88(5):889-99. PubMed ID: 19118548
[TBL] [Abstract][Full Text] [Related]
17. Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1.
Doi K; Murata K; Ito S; Suzuki A; Terao C; Ishie S; Umemoto A; Murotani Y; Nishitani K; Yoshitomi H; Fujii T; Watanabe R; Hashimoto M; Murakami K; Tanaka M; Ito H; Park-Min KH; Ivashkiv LB; Morinobu A; Matsuda S
Arthritis Rheumatol; 2022 Jun; 74(6):948-960. PubMed ID: 35077015
[TBL] [Abstract][Full Text] [Related]
18. The effect of molecules in mother-of-pearl on the decrease in bone resorption through the inhibition of osteoclast cathepsin K.
Duplat D; Gallet M; Berland S; Marie A; Dubost L; Rousseau M; Kamel S; Milet C; Brazier M; Lopez E; Bédouet L
Biomaterials; 2007 Nov; 28(32):4769-78. PubMed ID: 17686515
[TBL] [Abstract][Full Text] [Related]
19. Osteoclast lineage and function.
Väänänen HK; Laitala-Leinonen T
Arch Biochem Biophys; 2008 May; 473(2):132-8. PubMed ID: 18424258
[TBL] [Abstract][Full Text] [Related]
20. Different cysteine proteinases involved in bone resorption and osteoclast formation.
Brage M; Abrahamson M; Lindström V; Grubb A; Lerner UH
Calcif Tissue Int; 2005 Jun; 76(6):439-47. PubMed ID: 15906014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]